Biofrontera Inc. (BFRIW)
0.07
0.02 (40.56%)
At close: Apr 14, 2025, 1:58 PM
0.07
0.00%
After-hours: Apr 14, 2025, 04:00 PM EDT
40.56% (1D)
| Bid | 0.05 |
| Market Cap | 9.73M |
| Revenue (ttm) | 37.3M |
| Net Income (ttm) | -17.76M |
| EPS (ttm) | -1.296 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.08 |
| Volume | 3,810 |
| Avg. Volume (20D) | 15,398.388 |
| Open | 0.05 |
| Previous Close | 0.05 |
| Day's Range | 0.05 - 0.07 |
| 52-Week Range | 0.05 - 0.07 |
| Beta | 0.37 |
About BFRIW
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xe...
Sector Healthcare
IPO Date n/a
Employees 92
Stock Exchange NASDAQ
Ticker Symbol BFRIW
Website https://www.biofrontera-us.com